Treatment of Parathyroid Disease Market, Global Outlook and Forecast 2024-2030
The global Treatment of Parathyroid Disease market was valued at US$ 1289.3 million in 2023 and is projected to reach US$ 1933.7 million by 2030, at a CAGR of 6.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Calcitriol Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Treatment of Parathyroid Disease include CTTQ, Roche, Future Health Pharma, KPC Pharmaceuticals, Teva Pharmaceutical, Nantong Huashan Pharmaceutical, Teijin Pharma, Kyowa Kirin and Cheplapharm Arzneimittel, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
The parathyroid glands are four small glands located in the neck that produce parathyroid hormone (PTH), which regulates the levels of calcium and phosphorus in the body. There are several drugs that can affect the function of the parathyroid gland or the levels of PTH in the body.
This report aims to provide a comprehensive presentation of the global market for Treatment of Parathyroid Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Treatment of Parathyroid Disease. This report contains market size and forecasts of Treatment of Parathyroid Disease in global, including the following market information:
- Global Treatment of Parathyroid Disease Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Treatment of Parathyroid Disease Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Treatment of Parathyroid Disease companies in 2023 (%)
We surveyed the Treatment of Parathyroid Disease manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Treatment of Parathyroid Disease Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Treatment of Parathyroid Disease Market Segment Percentages, by Type, 2023 (%)
- Calcitriol
- Alfacalcidol
- Salmon Calcitonin
- Paricalcitol
- Other
Global Treatment of Parathyroid Disease Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Treatment of Parathyroid Disease Market Segment Percentages, by Application, 2023 (%)
Global Treatment of Parathyroid Disease Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Treatment of Parathyroid Disease Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Treatment of Parathyroid Disease revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Treatment of Parathyroid Disease revenues share in global market, 2023 (%)
- Key companies Treatment of Parathyroid Disease sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Treatment of Parathyroid Disease sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- CTTQ
- Roche
- Future Health Pharma
- KPC Pharmaceuticals
- Teva Pharmaceutical
- Nantong Huashan Pharmaceutical
- Teijin Pharma
- Kyowa Kirin
- Cheplapharm Arzneimittel
- Jiangsu Hengrui Pharmaceuticals
- Novartis
- Chongqing Yaoyou Pharmaceutical
- AbbVie
- Hebei Renhe Yikang Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Treatment of Parathyroid Disease, market overview.
Chapter 2: Global Treatment of Parathyroid Disease market size in revenue and volume.
Chapter 3: Detailed analysis of Treatment of Parathyroid Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Treatment of Parathyroid Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Treatment of Parathyroid Disease capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
